SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

IOL Chemicals and Pharmaceuticals informs about issuance letter of confirmation

21 Nov 2024 Evaluate

In continuation to its earlier intimation of lost share certificates submitted on 5 th November 2024 pursuant to the Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in accordance with the SEBI Notification No. SEBI/LAD-NRO/GN/2022/66 dated 24th January 2022 read with SEBI Circular No. SEBI/HO/MIRSD/MIRSD_RTAMB/P/CIR/2022/8 dated 25th January 2022, IOL Chemicals and Pharmaceuticals has informed that the Company/RTA has issued letter of confirmation dated 21st November 2024 to the shareholders in lieu of the lost share certificates as per details enclosed.

The above information is a part of company’s filings submitted to BSE.

IOL Chem & Pharma Share Price

91.16 5.66 (6.62%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×